12 employees
Amyloid Solution is a developer of therapy intended to overcome Alzheimer by developing modifying treatments.
$2.7M sweet spot round size
Most of their 1 investments are in rounds between $2.7M and $2.7M
2017
Deargen raised $2.7M on October 26, 2020
Investors: Hana Ventures and Amyloid Solution Inc.